Compare RCKY & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKY | SXTC |
|---|---|---|
| Founded | 1932 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.3M | 184.5M |
| IPO Year | 1993 | 2019 |
| Metric | RCKY | SXTC |
|---|---|---|
| Price | $29.07 | $1.41 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | 56.1K | ★ 259.7K |
| Earning Date | 10-28-2025 | 01-01-0001 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | ★ 53.66 | N/A |
| EPS | ★ 2.74 | N/A |
| Revenue | ★ $470,314,000.00 | $1,740,907.00 |
| Revenue This Year | $7.09 | N/A |
| Revenue Next Year | $4.27 | N/A |
| P/E Ratio | $10.61 | ★ N/A |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $11.93 | $0.95 |
| 52 Week High | $33.40 | $7.84 |
| Indicator | RCKY | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 46.24 |
| Support Level | $28.68 | $1.35 |
| Resistance Level | $30.80 | $1.45 |
| Average True Range (ATR) | 1.11 | 0.08 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 16.21 | 27.27 |
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.